{
    "code": "02013027",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02013027",
    "time": "2021-10-01 03:12:07",
    "許可證字號": "衛署藥輸字第013027號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/09\/25",
    "發證日期": "89\/11\/21",
    "許可證種類": "製　劑",
    "舊證字號": "02013027",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00201302708",
    "中文品名": "新體睦口服溶液每毫升100毫克",
    "英文品名": "SANDIMMUN NEORAL ORAL SOLUTION 100MG\/ML",
    "適應症": "預防器官移植及骨髓移植後之移植排斥、預防移植反宿主疾病、活動性有失明危險之中部或後部非感染性葡萄膜炎、使用傳統療法無法控制者、BECHET病一再發炎、且已侵犯視網膜者、替代性療法無效或不適用之嚴重性乾癬、標準療法無效或不適用之嚴重類風濕性關節炎、以類固醇治療無效或對類固醇有依賴性的原發性腎病症候群(活體檢視(BIOPSY))主要為微小病變疾病或局部環節腎絲球硬化症)，經細胞穩定(CYTOSTATIC)治療無效且腎功能指數在正常值50%以上之病人。後天型嚴重再生不良性貧血。異位性皮膚炎。",
    "劑型": "180液劑",
    "包裝": "50公撮(附刻度吸管兩支)瓶裝附量器",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CYCLOSPORIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1422701100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250000700",
            "成分名稱": "CYCLOSPORIN",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "013027_Sandimmun neoral oral solution 100mgml-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Draft_SandimmunNeoralSGC25 and OS_TWI-310720_Ch-109-08-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=012&Type=9"
        },
        {
            "title": "Neoral OS label-108-10-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=004&Type=8"
        },
        {
            "title": "Neoral OS FB-108-10-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=003&Type=8"
        },
        {
            "title": "3-2_NeoralOS_LBL_Ch-108-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=002&Type=8"
        },
        {
            "title": "3-1_NeoralOS_FB_Ch (002)-108-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013027&Seq=001&Type=8"
        }
    ]
}